A Phase I Study of Temsirolimus, Topotecan, and Bortezomib in Patients with Advanced Malignancy.

Trial Profile

A Phase I Study of Temsirolimus, Topotecan, and Bortezomib in Patients with Advanced Malignancy.

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Feb 2013

At a glance

  • Drugs Bortezomib (Primary) ; Temsirolimus (Primary) ; Topotecan (Primary)
  • Indications Cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Nov 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 29 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by M.D. Anderson Cancer Center.
    • 14 Oct 2008 Integrated ClinicalTrials.gov record NCT00770731.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top